Quick Answer
ClearPoint Neuro, Inc. reported Stockholders Equity of $28.02 million for fiscal year 2025.
ClearPoint Neuro, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $28.02M | +10.4% |
| 2024 | $25.39M | +19.9% |
| 2023 | $21.17M | -42.6% |
| 2022 | $36.89M | -24.4% |
| 2021 | $48.79M | +1952.5% |
| 2020 | $2.38M | -48.2% |
| 2019 | $4.59M | +203.7% |
| 2018 | $1.51M | -74.1% |
| 2017 | $5.83M | +870.9% |
| 2016 | -$756.1K | +61.8% |
| 2015 | -$1.98M | -1874.6% |
| 2014 | -$100.3K | +98.5% |
| 2013 | -$6.83M | +13.1% |
| 2012 | -$7.87M | +64.0% |
| 2011 | -$21.84M | -42.4% |
| 2010 | -$15.34M | -55.1% |
| 2009 | -$9.89M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $15.87M | -45.3% | -19.6% |
| June 30, 2025 | $19.74M | -38.6% | -1.2% |
| March 31, 2025 | $19.99M | -42.2% | -21.3% |
| December 31, 2024 | $25.39M | +19.9% | -12.5% |
| September 30, 2024 | $29.00M | +20.4% | -9.7% |
| June 30, 2024 | $32.13M | +17.2% | -7.1% |
| March 31, 2024 | $34.58M | +6.2% | +63.3% |
| December 31, 2023 | $21.17M | -42.6% | -12.1% |
- ClearPoint Neuro, Inc. showed an increase of +10.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, ClearPoint Neuro, Inc.’s stockholders equity has grown by 383.4% (from -$9.89 million to $28.02 million).
- The most recent figure is from ClearPoint Neuro, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: